Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Rose Lorenzo, BA
Senior Director of Research,
Kantar Health,
New York, NY.
Ms Lorenzo is Senior Director of Research, Kantar Health, New York, NY.
Authored Items
Patient Preferences and Treatment Adherence Among Women Diagnosed with Metastatic Breast Cancer
Albert Tzeel, MD, MHSA, CPE, FAAPL
,
Marco daCosta DiBonaventura, PhD
,
Ronda Copher, PhD
,
Enrique Basurto, MSc
,
Claudio Faria, PharmD, MPH
,
Rose Lorenzo, BA
October 2014 Vol 7, No 7
in
Original Research
Last modified: November 3, 2014